Search
Feedback
About UniCat 
Help
News
| Listing 1 - 10 of 175 | << page >> |
Sort by
|
Book
Year: 1966 Publisher: New York, NY London : Academic Press,
Abstract | Keywords | Export | Availability | Bookmark
Loading...Choose an application
- Reference Manager
- EndNote
- RefWorks (Direct export to RefWorks)
Book
Year: 1966 Publisher: New York, NY London : Academic Press,
Abstract | Keywords | Export | Availability | Bookmark
Loading...Choose an application
- Reference Manager
- EndNote
- RefWorks (Direct export to RefWorks)
Book
Year: 1963 Publisher: New York, NY London : Academic Press,
Abstract | Keywords | Export | Availability | Bookmark
Loading...Choose an application
- Reference Manager
- EndNote
- RefWorks (Direct export to RefWorks)
Book
ISBN: 0127392017 Year: 1963 Publisher: New York : Academic Press,
Abstract | Keywords | Export | Availability | Bookmark
Loading...Choose an application
- Reference Manager
- EndNote
- RefWorks (Direct export to RefWorks)
Enzyme Inhibitors. --- Enzyme inhibitors. --- Enzyme inhibitors. --- Antienzymes
Book
Year: 1975 Publisher: New York, N.Y.: Krieger,
Abstract | Keywords | Export | Availability | Bookmark
Loading...Choose an application
- Reference Manager
- EndNote
- RefWorks (Direct export to RefWorks)
Book
Year: 1965 Publisher: New York (N.Y.) : Academic press,
Abstract | Keywords | Export | Availability | Bookmark
Loading...Choose an application
- Reference Manager
- EndNote
- RefWorks (Direct export to RefWorks)
Book
Abstract | Keywords | Export | Availability | Bookmark
Loading...Choose an application
- Reference Manager
- EndNote
- RefWorks (Direct export to RefWorks)
Book
ISBN: 9811460825 9789811460821 Year: 2020 Publisher: [Place of publication not identified] BENTHAM Science PUBLISHER
Abstract | Keywords | Export | Availability | Bookmark
Loading...Choose an application
- Reference Manager
- EndNote
- RefWorks (Direct export to RefWorks)
Book
Year: 2018 Publisher: Ottawa (ON) : Canadian Agency for Drugs and Technologies in Health,
Abstract | Keywords | Export | Availability | Bookmark
Loading...Choose an application
- Reference Manager
- EndNote
- RefWorks (Direct export to RefWorks)
Nitisinone (MDK-Nitisinone) is an inhibitor of the tyrosine catabolic pathway and is indicated for patients with hereditary tyrosinemia type 1 (HT-1), in combination with dietary restriction of tyrosine and phenylalanine. Nitisinone is available as 2 mg, 5 mg, 10 mg, and 20 mg capsules. The submitted price of nitisinone is based on dose: (2 mg $14.78), 5 mg (
Book
Year: 2018 Publisher: Ottawa (ON) : Canadian Agency for Drugs and Technologies in Health,
Abstract | Keywords | Export | Availability | Bookmark
Loading...Choose an application
- Reference Manager
- EndNote
- RefWorks (Direct export to RefWorks)
Nitisinone (MDK-Nitisinone) is an inhibitor of the tyrosine catabolic pathway and is indicated for patients with hereditary tyrosinemia type 1 (HT-1), in combination with dietary restriction of tyrosine and phenylalanine. Nitisinone is available as 2 mg, 5 mg, 10 mg, and 20 mg capsules. The submitted price of nitisinone is based on dose: (2 mg $14.78), 5 mg (
| Listing 1 - 10 of 175 | << page >> |
Sort by
|